Fundraising Fox

Versant Venture AIV HoldingsFull Portfolio

14 tracked investments · listed companies and verified rows first

Edwards Lifesciencesedwards.comin𝕏NYSE: EWJan 2017SEC filingmedium confidence

BiotechHealthtechMedical DevicesIrvine, US

Donald E. Bobo, Jr.(Executive Officer)Scott B. Ullem(Executive Officer)Larry L. Wood(Executive Officer)Huimin Wang(Executive Officer)Catherine M. Szyman(Executive Officer)Bernard J. Zovighian(Executive Officer)

Board seatWilliam J. Link· per SEC Form D · $272.4M raise · filed Feb 2017

Co-investorsALIVE Israel HealthTech Fund

Lensarlensar.comNASDAQ: LNSRMay 2023SEC filingmedium confidence

HealthtechOrlando, US

Alan B Connaughton(Executive Officer)Amy R Brooks(Executive Officer)Peter J Mariani(Executive Officer)Nicholas T Curtis(Executive Officer, Director)Randy W Frey(Director)Keith H Edwards(Executive Officer)

Board seatWilliam J. Link· per SEC Form D · $20M raise · filed May 2023

Co-investorsAisling Capital

Rxsightrxsight.comin𝕏NASDAQ: RXSTFeb 2017SEC filingmedium confidence

RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.

HealthtechMedical DevicesPasadena, US

Joseph Devivo(Director)James N. Adler(Director)Robert H. Grubbs(Director)Werner F. Wolfen(Director)D. Verne Sharma(Executive Officer, Director)Javier Perez-Sala(Director)

Board seatWilliam Link· per SEC Form D · $77.5M raise · filed Apr 2017

Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA Capital+1 more

Second Sight Medical ProductsNASDAQ: VANIAug 2018SEC filingmedium confidence

BiotechHealthtechSylmar, US

Edward Sedo(Acting Chief Accounting Officer)Scott Dunbar(Acting CEO)Aaron Mendelsohn(Director)TOM FOGERTY(Director)WILLIAM LINK(Director)ALFRED MANN(Director)

Board seatWilliam Link· per SEC Form D · $5M raise · filed Aug 2018

AcuFocus, Inc.acufocus.comAug 2016SEC filingmedium confidence

BiotechIrvine, US

Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)Ryan M. Schwarz(Director)Charles Warden(Director)Charles Larsen(Director)

Board seatWilliam J. Link· per SEC Form D · $2M raise · filed Aug 2016

Co-investorsEvidity Health CapitalFlying L Partners

Allegro OphthalmicsMay 2017SEC filingmedium confidence

BiotechSan Juan Capistrano, US

Hampar Karageozian(Member of Board of Managers and Chief Executive Officer)Vicken Karageozian(Member of Board of Managers and Chief Technical Officer)John Park(Executive Officer, Director)Marc D. Kirshbaum(Member of Board of Managers and Chief Operating Officer)

BoardA. Thomas Bender(Member of Board of Managers)Robert Byrnes(Member of Board of Managers)

Board seatWilliam LinkWilliam J. Link· per SEC Form D · $13.5M raise · filed Jan 2019

Equinox Ophthalmic, Inc.equinoxus.comAug 2019SEC filingmedium confidence

HealthtechSioux Falls, US

TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)

BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)

Board seatWilliam Link· per SEC Form D · $22M raise · filed Sep 2019

Co-investorsFlying L Partners

eyeBrain MedicalNov 2017SEC filingmedium confidence

BiotechNewport Beach, US

Davis Corley(Executive Officer)J. Andy Corley(Executive Officer, Director, Promoter)

Board seatWilliam LinkWilliam T. Link· per SEC Form D · $15M raise · filed Jun 2022

Co-investorsMVM Life Science Partners

OneFocus VisionJun 2015SEC filingmedium confidence

HealthtechFernandina Beach, US

Steve Waite(Executive Officer, Director)

BoardWarren Thaler(Director)Ed Peterson(Director)Stephen Martin(Director)

Board seatWilliam Link· per SEC Form D · $2.2M raise · filed Jul 2015

Oyster Point Pharma, Inc.oysterpointrx.comin𝕏Oct 2017SEC filingmedium confidence

A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.

BiotechHealthtechSan Francisco, US

Jeffrey Nau(Executive Officer, Director)Mark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)

BoardAli Behbahani(Director)in

Board seatWilliam J Link· per SEC Form D · $43.1M raise · filed Oct 2017

Co-investorsFlying L PartnersNew Enterprise Associates (NEA)

Prelude CorpFeb 2016SEC filingmedium confidence

Laguna Hills, US

Board seatWilliam J. LinkWilliam Link· per SEC Form D · $5.5M raise · filed Mar 2017

Sightlife SurgicalOct 2016SEC filingmedium confidence

HealthtechSeattle, US

TIM MCLAUGHLIN(Executive Officer)MONTY MONTOYA(Executive Officer, Director)

BoardKUSH PARIKH(Director)RICHARD LINDSTROM(Director)MELODY SUMMERS(Director)

Board seatWilliam Link· per SEC Form D · $10M raise · filed Oct 2016

TearCleartearclear.comMay 2017SEC filingmedium confidence

BiotechCopley, US

Kevin Hershfield(Executive Officer, Director)

BoardJeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)

Board seatWilliam Link· per SEC Form D · $4.6M raise · filed May 2017

Co-investorsFlying L PartnersVisionary Ventures

ViaLasevialase.cominMar 2019SEC filingmedium confidence

ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma.

Deep TechHealthtechMedical DevicesAliso Viejo, US

Tibor Juhasz(Executive Officer, Director)Rick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)Shawn O'Neil(Executive Officer)in

Board seatWilliam Link· per SEC Form D · $8.1M raise · filed Apr 2019

Co-investorsArboretum Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.